1 You read that right: It wasnt originally designed as a weight loss drug at all
The best outcomes typically come from steady dosing, consistent habits, and regular check ins
We risk treating them as a weight-loss trend or a small group of users that arent significant, but their needs should be recognised and acknowledged as one that is rising rapidly. Heres what they want and why
Areas Requiring Further Investigation Further research is needed to clarify long-range receptor signaling behavior, tissue-specific pathway effects, molecular signaling durability, model-to-human translation, and how findings vary across study designs
GLP-1 Receptor Agonists (Nauck et al., New England Journal of Medicine)
34ThompsonSM, VellaA, ThompsonGB,